Saag, Michael S.

Antibody neutralization and escape by HIV-1

Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature

HIV Research and TreatmentSARS-CoV-2 and COVID-19 Research

Cited by 2,421

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy

Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 1,569

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., et al. (2018) · JAMA

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 698

Azole antifungal agents: Emphasis on new triazoles

Saag, M. S., & Dismukes, W. E. (1988) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 474

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel

Schambelan, M., Benson, C. A., Carr, A., Currier, J. S., Dubé, M. P., Gerber, J. G., Grinspoon, S. K., Grunfeld, C., Kotler, D. P., Mulligan, K., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes

HIV-related health complications and treatmentsHIV/AIDS drug development and treatment

Cited by 379

Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society-USA Panel

Gandhi, R. T., Landovitz, R. J., Sax, P. E., Smith, D. M., Springer, S. A., Günthard, H. F., Thompson, M. A., Bedimo, R. J., Benson, C. A., Buchbinder, S. P., et al. (2025) · JAMA

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 265

Aging With HIV: A Cross-Sectional Study of Comorbidity Prevalence and Clinical Characteristics Across Decades of Life

Vance, D. E., Mugavero, M., Willig, J., Raper, J. L., & Saag, M. S. (2011) · Journal of the Association of Nurses in AIDS Care

HIV-related health complications and treatmentsHIV/AIDS Research and Interventions

Cited by 213

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

Crane, H. M., McCaul, M. E., Chander, G., Hutton, H., Nance, R. M., Delaney, J. A. C., Merrill, J. O., Lau, B., Mayer, K. H., Mugavero, M. J., et al. (2017) · AIDS and Behavior

Substance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk

Cited by 125

Treatment of Fluconazole-Refractory Oropharyngeal Candidiasis with Itraconazole Oral Solution in HIV-Positive Patients

Saag, M. S., Fessel, W. J., Kaufman, C. A., Merrill, K. W., Ward, D. J., Moskovitz, B. L., Thomas, C., Oleka, N., Guarnieri, J. A., Lee, J., et al. (1999) · AIDS Research and Human Retroviruses

Antifungal resistance and susceptibilityHIV/AIDS oral health manifestations

Cited by 79

A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV

Cropsey, K. L., Hendricks, P. S., Jardin, B., Clark, C. B., Katiyar, N., Willig, J., Mugavero, M., Raper, J. L., Saag, M., & Carpenter, M. J. (2013) · Addictive Behaviors

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 46